Jamshed Shazia Q, Siddiqui Mohammand J, Rana Bareera, Bhagavathula Akshaya S
Pharmacy Practice, International Islamic University Malaysia, Selayang, Malaysia.
University of Veterinary and Animal Sciences, Lahore, Pakistan.
Front Public Health. 2018 Sep 3;6:244. doi: 10.3389/fpubh.2018.00244. eCollection 2018.
To analyze the studies encompassing the involvement of pharmacists in diabetes self-care. We reviewed studies conducted from 2005 to 2017 on the involvement of pharmacists in diabetes self-care. The keywords mainly used in this search are pharmacoeconomic analysis, diabetes self-care, pharmacist involvement,cost-effectiveness analysis, cost of utilization, cost of illness, cost of minimization and cost-benefit analysis. PubMed, Science Direct, Springer Link and Medline searched for the relevant studies. These databases searched for full text articles ranging from 2007 to 2017. We tried to limit the search with the inclusion of studies having any sort of pharmacoeconomically relevant component. Cost of illness varied among the countries in managing diabetes mellitus, and the cost of managing diabetes complications were twice the cost of management of diabetes. Continuous involvement of the pharmacist in primary health care is a cost-effective strategy and pronounced to be essential for helping diabetes patient in controlling and managing their disease. Implementation of diabetes self-care by pharmacists such as lifestyle intervention rendered improved quality of life of patient without any increase in health care cost. Self-care management generates intensive blood glucose control and improved quality of life. Implementation of diabetic self-care intervention including intensive lifestyle intervention, education, self-monitoring of blood glucose and adherence toward medication-initiated reduction in the overall healthcare cost of diabetic patients compared to patients relying on only any one of the interventions. Impact of diabetes self-care intervention by pharmacist reported to significantly reduce the HbA1C levels of diabetic patients along with the reduction of yearly healthcare cost. This review showed that pharmacist involvement in diabetes self-care interventions prove to be cost-effective and can significantly affect the condition of the diabetic patients and reduces the risk of complications.
分析涉及药剂师参与糖尿病自我管理的研究。我们回顾了2005年至2017年期间关于药剂师参与糖尿病自我管理的研究。本次检索主要使用的关键词有药物经济学分析、糖尿病自我管理、药剂师参与、成本效益分析、使用成本、疾病成本、成本最小化和成本效益分析。通过PubMed、Science Direct、Springer Link和Medline检索相关研究。这些数据库检索了2007年至2017年的全文文章。我们试图通过纳入任何具有药物经济学相关成分的研究来限制检索范围。各国在糖尿病管理方面的疾病成本各不相同,糖尿病并发症的管理成本是糖尿病管理成本的两倍。药剂师持续参与初级卫生保健是一种具有成本效益的策略,对于帮助糖尿病患者控制和管理疾病至关重要。药剂师实施糖尿病自我管理,如生活方式干预,可提高患者生活质量,且不会增加医疗保健成本。自我管理可实现强化血糖控制并改善生活质量。与仅依赖任何一种干预措施的患者相比,实施包括强化生活方式干预、教育、血糖自我监测和药物依从性在内的糖尿病自我管理干预措施可降低糖尿病患者的总体医疗保健成本。据报道,药剂师进行的糖尿病自我管理干预措施的影响可显著降低糖尿病患者的糖化血红蛋白水平,并降低年度医疗保健成本。本综述表明,药剂师参与糖尿病自我管理干预措施被证明具有成本效益,可显著影响糖尿病患者的病情并降低并发症风险。